<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Prognosis of depression in old age
2
Prognosis of depression with and without dementia in old age
3
Prognosis of diabetes in the developing world
4
Prognosis of emergency room stabilization of decompensated congestive heart failure with high dose lasix
5
Prognosis of environmental concentrations by geo-referenced and generic models: a comparison of GREAT-ER and EUSES exposure simulations for some consumer-product ingredients in the Itter
6
Prognosis of fasting in patients with cerebral venous thrombosis using oral contraceptives
7
Prognosis of fatigue. A systematic review
8
Prognosis of Guillain-Barré Syndrome in Children
9
Prognosis of Hepatic Amyloidosis Status and Insufficiency in Snake Antivenom Producing Horses
10
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
11
Prognosis of Idiopathic Recurrent Pericarditis as Determined from Previously Published Reports
12
Prognosis of infants with ankle clonus within the first year of life
13
Prognosis of left ventricular geometric patterns in the Framingham heart study
14
Prognosis of left ventricular hypertrabeculation/noncompaction is dependent on cardiac and neuromuscular comorbidity
15
Prognosis of Lung Cancer in Heart Transplant Recipient
16
Prognosis of medically stabilized unstable angina pectoris with a negative exercise test
17
Prognosis of medically treated patients referred for cardiac transplantation
18
Prognosis of Negative Adenosine Stress Magnetic Resonance in Patients Presenting to an Emergency Department With Chest Pain Original Research Article
19
Prognosis of osteopenia in chronic alcoholics
20
Prognosis of patients ≽70 years of age with non-Q-wave acute myocardial infarction compared with younger patients with similar infarcts and with patients ≥70 years of age with Q-wave acute myocardial infarction
21
Prognosis of Patients Taking Selective Serotonin Reuptake Inhibitors Before Coronary Artery Bypass Grafting
22
Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction
23
Prognosis of patients with a first episode of sustained monomorphic ventricular tachycardia
24
Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era, , ,
25
Prognosis of patients with a recurrent acute myocardial infarction before and in the reperfusion era—A national study
26
Prognosis of patients with atherothrombotic disease: A prospective survey in a non-hospital setting
27
Prognosis of patients with locally recurrent breast cancer
28
Prognosis of patients with non-malignant chronic intestinal failure receiving long-term home parenteral nutrition
29
Prognosis of Patients with Primary Systemic Amyloidosis Who Present with Dominant Neuropathy
30
Prognosis of patients with severe left ventricular dysfunction after coronary artery bypass grafting
31
Prognosis of Patients With Stable Coronary Artery Disease (from the CORONOR Study)
32
Prognosis of patients with unstable angina and low-risk exercise test: significance of ST-segment depression on the admission ECG
33
Prognosis of patients with vascular disease after clinical evaluation and dobutamine stress echocardiography
34
Prognosis of pregnancy-associated breast cancer: A meta-analysis of 30 studies
35
Prognosis of prostate cancer by artificial neural networks
36
Prognosis of seizure recurrence after stopping antiepileptic drugs in seizure-free patients: A long-term population-based study of childhood-onset epilepsy
37
Prognosis of spontaneous echocardiographic contrast in the thoracic aorta
38
Prognosis of stage III or IV primary peritoneal serous papillary carcinoma
39
Prognosis of Subjects With Brugada-Type Electrocardiogram in a Population of Middle-Aged Japanese Diagnosed During a Health Examination
40
Prognosis of sudden deafness with special reference to risk factors of microvascular pathology
41
Prognosis of thin cutaneous head and neck melanoma (<1 mm)
42
Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification
43
Prognosis of Time to Failure of Corroding Pipelines
44
Prognosis of TiO2 abundance in lunar soil using a non-linear analysis of Clementine and LSCC data
45
Prognosis of Traumatic Injuries to the Anterior Teeth (Treated in Shahid Beheshti and Tehran Dental Schools During 1996-2001)
46
Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia
47
Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia
48
Prognostic Accuracy of B-Natriuretic Peptide Measurements and Coronary Artery Calcium in Asymptomatic Subjects (from the Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research [EISNER] Study)
49
Prognostic and Clinical Value of CD44 and CD133 in Esophageal Cancer: A Systematic Review and Meta-analysis
50
Prognostic and Demographic Characteristics of Acute Myelogenous Leukemia Patients: a FiveYear Study in Mashhad, Iran
51
Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer
52
Prognostic and predictive biomarkers of canine osteosarcoma
53
Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: A single institute experience
54
Prognostic and predictive factors in breast cancer
55
Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team
56
Prognostic and predictive factors in prostate cancer
57
Prognostic and predictive factors revisited
58
Prognostic and predictive value of 16p12.1 and 16q22.1 copy number changes in human breast cancer
59
Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer
60
Prognostic application of arterial stiffness: task forces
61
Prognostic Assessment of Coronary Artery Bypass Patients With 64-Slice Computed Tomography Angiography: Anatomical Information Is Incremental to Clinical Risk Prediction
62
Prognostic Associations of Minnesota Code Serial Electrocardiographic Change Classification With Coronary Heart Disease Mortality in the Multiple Risk Factor Intervention Trial
63
Prognostic Biomarkers in ST-Segment Elevation Myocardial Infarction: A Step Toward Personalized Medicine or a Tool in Search of an Application?
64
Prognostic classification of breast ductal carcinoma-in-situ
65
prognostic computer model to predict individual outcome in interventional cardiology—The INTERVENT project
66
Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer
67
Prognostic Cut Point for Breast Cancer Age of Diagnosis
68
Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone
69
Prognostic differences between atrial fibrillation and atrial flutter
70
Prognostic Effect of Coronary Flow Reserve in Women Versus Men With Chest Pain Syndrome and Normal Dipyridamole Stress Echocardiography
71
Prognostic Effect of Long-Axis Left Ventricular Dysfunction and B-Type Natriuretic Peptide Levels in Asymptomatic Aortic Stenosis
72
Prognostic effect of renal dysfunction after ST-segment elevation myocardial infarction with and without heart failure
73
Prognostic effect of serum and tissue YKL-40 levels in bladder cancer
74
Prognostic Effects of Selective Serotonin Reuptake Inhibitors in Patients With Coronary Artery Bypass Grafting
75
Prognostic Evaluation by Clinical Exercise Test Scores in Patients Treated With Primary Percutaneous Coronary Intervention or Fibrinolysis for Acute Myocardial Infarction (a Danish Trial in Acute Myocardial Infarction-2 Sub-Study)
76
Prognostic Evaluation of Ambulatory Patients With Advanced Heart Failure
77
Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction
78
Prognostic evaluation of patients with parenchymal cirrhosis : Proposal of a new simple score
79
Prognostic evaluation of preoperative combined treatment for advanced cancer in the lower rectum with radiation, intraluminal hyperthermia, and 5-fluorouracil suppository
80
Prognostic Factors Affecting the Results of Modified Thompson Quadricepsplasty for the Treatment of Extension Contracture of the Knee
81
Prognostic factors after resection of hepatocellular carcinoma: are there landmarks in the wild forest?
82
Prognostic factors after surgery for locally recurrent rectal cancer: An overview
83
Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours
84
Prognostic factors after surgical treatment of lung cancer invading the diaphragm
85
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma
86
Prognostic factors and clinicopathologic characteristics of invasive adenocarcinoma of the uterine cervix
87
Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)
88
Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis
89
PROGNOSTIC FACTORS AND MORTALITY RATE IN NEONATES WITH ACUTE RENAL INJURY IN NICU
90
Prognostic factors and new therapeutic approaches to cervical cancer
91
Prognostic factors and outcome in women with uterine sarcoma
92
Prognostic factors and preoperative radiation therapy associated with sphincter preservation in patients with resectable rectal cancer
93
Prognostic factors and relative risk for survival in N1–3 oral squamous cell carcinoma: a multivariate analysis using Cox’s hazard model
94
Prognostic factors and results after surgical treatment of primary sarcomas of the lung
95
Prognostic Factors and Surgical Indications of Pulmonary Epithelioid Hemangioendothelioma: A Review of the Literature
96
Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients
97
Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients
98
Prognostic factors associated with antenatal subchorionic echolucencies
99
Prognostic factors associated with pressure sore development in the immediate post-operative period
100
Prognostic factors associated with the clinical outcome of cervical intraepithelial neoplasia: a cohort study in Japan
101
Prognostic factors for atherosclerosis progression in saphenous vein grafts : The postcoronary artery bypass graft (post-CABG) trial
102
Prognostic factors for chronic neck pain in persons with Minor or moderate injuries in traffic accidents
103
Prognostic factors for cryotherapy of colorectal liver metastases
104
Prognostic factors for first recurrence in patients with retroperitoneal sarcoma
105
Prognostic Factors for Fournier’s Gangrene; A 10-year Experience in Southeastern Iran
106
Prognostic factors for gastric cancer in the elderly
107
Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy
108
Prognostic Factors for Improvement of Attention Deficit Hyperactivity Disorder (ADHD)
109
Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases
110
Prognostic factors for renal cell carcinoma
111
Prognostic factors for skeletal relapse in breast cancer
112
Prognostic factors for success of endometrial ablation and resection
113
Prognostic factors for success of endometrial ablation and resection
114
Prognostic factors for survival after isolated limb perfusion for malignant melanoma
115
Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma
116
PROGNOSTIC FACTORS FOR SURVIVAL AT 6-MONTH FOLLOW-UP OF HOSPITALIZED PATIENTS WITH DECOMPENSATED CONGESTIVE HEART FAILURE
117
Prognostic factors for survival in pancreatic cancer: a population-based study
118
Prognostic Factors for Survival in Patients with Colorectal Cancer in Iran between 2004-2015: Competing Risks Regression Analysis with Generalized Weibull Model
119
Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. Motzer RJ, Bacik J, Schwartz LH, Reuter V, Russo P, Marion S, Mazumdar M, Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of
120
Prognostic factors for the development of gangrenous cholecystitis
121
Prognostic factors for the survival of patients with esophageal cancer in Northern Iran
122
Prognostic factors for tobacco consumption reduction after relapse
123
Prognostic factors for unstable proximal humeral fractures treated with locking-plate fixation
124
Prognostic factors in acute cardiogenic pulmonary edema
125
Prognostic factors in acute cardiogenic pulmonary edema
126
Prognostic factors in acute myeloid leukaemia
127
Prognostic factors in adenocarcinoma of the cardia
128
Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning
129
Prognostic factors in birth time: A Survival Analysis
130
Prognostic factors in clinical stage I non–small cell lung cancer
131
Prognostic factors in controlied ovarian hyperstimulation
132
Prognostic factors in follicular carcinoma of the thyroid—a multivariate survival analysis
133
Prognostic factors in hanging injuries
134
Prognostic factors in hereditary and sporadic breast cancers: analysis of an Italian series of 602 patients
135
Prognostic factors in intramedullary astrocytomas
136
Prognostic factors in major depression: A long-term follow-up study of 323 patients
137
Prognostic factors in maxillary sinus and nasal cavity carcinoma
138
Prognostic factors in metastatic prostate cancer
139
Prognostic factors in multiple myeloma: selection using Coxʹs proportional hazard model
140
Prognostic factors in neuroendocrine lung tumors: a Spanish multicenter study
141
Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis
142
Prognostic factors in non-small cell lung cancer surgery
143
Prognostic factors in patients continuing in vitro fertilization or intracytoplasmic sperm injection treatment and dropouts
144
Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients
145
Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients
146
Prognostic Factors in Patients With Implantable Cardioverter-Defibrillators
147
Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)
148
Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)
149
Prognostic factors in patients with malignant fibrous histiocytoma of the extremities
150
Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer
151
Prognostic Factors in Resected Satellite–Nodule T4 Non-Small Cell Lung Cancer
152
Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases
153
Prognostic factors in soft tissue sarcomas: a study of 395 patients
154
Prognostic factors in the palliation of pancreatic cancer
155
Prognostic Factors in the Relapse of Graves’ Disease Following Treatment with Antithyroid Drugs
156
Prognostic Factors in Thymic Epithelial Tumors Undergoing Complete Resection
157
PROGNOSTIC FACTORS IN TYPHOID ILEAL PERFORATION: A PROSPECTIVE STUDY OF 98 PATIENTS AT SAIDU GROUP OF TEACHING HOSPITALS, SWAT
158
Prognostic factors in metastatic nasopharyngeal carcinoma
159
Prognostic factors of 28 days survival rate in patients with a first acute myocardial
160
Prognostic Factors of Anaplastic Thyroid Carcinoma: An Egyptian Single Institution Experience
161
Prognostic Factors of Concomitant Hyperglycemia and Hypocalcemia in Pediatric Intensive Care Units
162
Prognostic Factors of Depression in Patients With Cancer Undergoing Chemotherapy and Radiotherapy
163
Prognostic factors of extremity soft tissue sarcoma in adults. A single institutional analysis
164
Prognostic factors of first birth interval using the parametric survival models
165
Prognostic factors of gastric cancer tumours of less than 2 cm in diameter: rationale for limited surgery
166
Prognostic factors of patients with yolk sac tumors of the ovary
167
Prognostic Factors of Pregnancy in 500 Cases of Intrauterine Insemination in Babol, Northern Iran
168
Prognostic Factors of Pregnancy in 500 Cases of Intrauterine Insemination in Babol, Northern Iran
169
Prognostic factors of recurrence and neck metastasis in oral carcinomas
170
Prognostic Factors of Renal Dysfunction Induced by Environmental Cadmium Pollution
171
Prognostic Factors of Survival Rate in Oral Squamous Cell Carcinoma: Clinical, Histologic, Genetic and Molecular Concepts
172
Prognostic factors of thymomas
173
Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients
174
Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients
175
Prognostic factors predicting survival in the treatment of retroperitoneal sarcoma
176
Prognostic features of multiple myeloma
177
Prognostic histopathological and molecular markers in feline mammary neoplasia
178
Prognostic Impact of Acute Beta-Blocker Therapy on Top of Aspirin and Angiotensin-Converting Enzyme Inhibitor Therapy in Consecutive Patients With ST-Elevation Acute Myocardial Infarction
179
Prognostic Impact of Adjuvant Radiotherapy in Breast Cancer Patients with One to Three Positive Axillary Lymph Nodes
180
Prognostic impact of ambulatory blood pressure control in treated hypertensive patients
181
Prognostic Impact of Angiotensin-Converting Enzyme Inhibitor Therapy in Diastolic Heart Failure
182
Prognostic impact of autonomic information flow in multiple organ dysfunction syndrome patients
183
Prognostic impact of big endothelin-1 plasm concentrations compared with invasive hemodynamic evaluation in severe heart failure
184
Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease
185
Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia
186
Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at diagnosis: A population-based, propensity score analysis
187
Prognostic impact of Deoxyribonucleic acid (DNA) image analysis cytometry and immunohistochemical expression of Ki67 in surgically resected non-small cell lung cancers
188
Prognostic Impact of Diabetes Mellitus in Patients With Acute Decompensated Heart Failure
189
Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction
190
Prognostic impact of DNA content and AUER classification in primary fallopian tube carcinoma
191
Prognostic impact of left bundle-branch block in the early stable phase after acute myocardial infarction
192
Prognostic impact of p53 protein overexpression in patients with node-negative lung adenocarcinoma
193
Prognostic impact of peakVO2-changes in stable CHF on chronic beta-blocker treatment
194
Prognostic impact of pre-operative albumin on short-term mortality and complications in patients with hip fracture
195
Prognostic impact of pulmonary arterial hypertension: A population-based analysis
196
Prognostic Impact of Pulmonary Artery Systolic Pressure in Patients Undergoing Transcatheter Aortic Valve Replacement for Aortic Stenosis
197
Prognostic Impact of Q Waves on Presentation and ST Resolution in Patients With ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
198
Prognostic impact of right ventricular involvement as assessed by tricuspid annular motion in patients with acute myocardial infarction
199
Prognostic Impact of Staged Versus “One-Time” Multivessel Percutaneous Intervention in Acute Myocardial Infarction: Analysis From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial
200
Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy
201
Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy
202
Prognostic Impact of Systolic Hypertension on Asymptomatic Patients With Chronic Severe Aortic Regurgitation and Initially Normal Left Ventricular Performance at Rest
203
Prognostic Impact of the Presence and Absence of Angina on Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Stable Coronary Artery Disease: Results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes)
204
Prognostic impact of tumor size on pT2 renal cell carcinoma: An international multicenter experience: Klatte T, Patard JJ, Goel RH, Kleid MD, Guille F, Lobel B, Abbou CC, De La Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Artibani W, Prayer-Galet
205
Prognostic impact of tumour cell detection in patients with early (T1) and locally advanced breast cancer
206
Prognostic Impact of Types of Atrial Fibrillation in Acute Coronary Syndromes
207
Prognostic impact of workload in patients with congestive heart failure
208
Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era
209
Prognostic implication of early ejection fraction on long-term mortality and quality of life following out-of-hospital cardiac arrest
210
Prognostic Implication of Hyperglycemia in Myocardial Infarction and Primary Angioplasty
211
Prognostic implication of Ki-67 immunostaining in treating subclinical pleural cancer found at thoracotomy in lung cancer patients
212
Prognostic implication of pretreatment plasma/serum concentration of Epstein-Barr virus DNA in nasopharyngeal carcinoma
213
Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal
214
Prognostic implication of troponin I elevation after percutaneous coronary intervention
215
Prognostic implication of valvular lesion and left ventricular size in asymptomatic patients with chronic organic mitral regurgitation and normal left ventricular performance
216
Prognostic implications derived from ultrasonic tissue characterization with myocardial integrated backscatter in patients with dilated cardiomyopathy
217
Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables
218
Prognostic Implications of a Normal Stress Technetium-99m–Tetrofosmin Myocardial Perfusion Study in Patients With a Healed Myocardial Infarct and/or Previous Coronary Revascularization
219
Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study In Stockholm [APSIS])
220
Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography Original Research Article
221
Prognostic implications of autonomic nervous system analysis in chronic heart failure: Role of heart rate variability and baroreflex sensitivity
222
Prognostic Implications of Baroreflex Sensitivity in Heart Failure Patients in the Beta-Blocking Era
223
Prognostic Implications of Bundle Branch Block in Patients Undergoing Primary Coronary Angioplasty in the Stent Era
224
Prognostic Implications of Coronary Flow Reserve on Left Anterior Descending Coronary Artery in Hypertrophic Cardiomyopathy
225
Prognostic Implications of Creatine Kinase Elevation After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction Original Research Article
226
Prognostic implications of detection of troponin I in patients with unstable angina pectoris
227
Prognostic Implications of Dipyridamole or Dobutamine Stress Echocardiography for Evaluation of Patients ≥65 Years of Age With Known or Suspected Coronary Heart Disease
228
Prognostic implications of ejection fraction from linear echocardiographic dimensions: the strong heart study
229
Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: A TACTICS-TIMI-18 substudy Original Research Article
230
Prognostic implications of elevated whole blood choline levels in acute coronary syndromes
231
Prognostic implications of evaluation of contractile reserve in akinetic and hypokinetic segments during low dose dobutamine echocardiography in patients with acute myocardial infarction
232
Prognostic Implications of Exercise Echocardiography in Women With Known or Suspected Coronary Artery Disease
233
Prognostic implications of fetal echogenic bowel
234
Prognostic implications of hyponatremia in elderly hospitalized patients
235
Prognostic implications of I-123 metaiodobenzylguanidine (MIBG) in patients with idiopathic dilated cardiomyopathy (DCM) and receiving β-blockade treatment
236
Prognostic implications of increased QRS duration in patients with moderate and severe left ventricular systolic dysfunction
237
Prognostic implications of inhalation injury in burn patients in Tokyo
238
Prognostic implications of intraventricular conduction defects in patients undergoing stress echocardiography for suspected coronary artery disease
239
Prognostic Implications of Left Atrial Volume Index in Patients in Sinus Rhythm
240
Prognostic implications of left ventricular hypertrophy
241
Prognostic Implications of Mental Stress-Induced Silent Loft Ventricular Dysfunction in Patients With Stable Angina Pectoris
242
Prognostic implications of microscopic proximal bronchial extension in non-small cell lung cancer
243
Prognostic implications of monosomy 3 in uveal melanoma
244
Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction
245
Prognostic implications of myocardial necrosis triad markersʹ concentration measured at admission in patients with suspected acute coronary syndrome
246
Prognostic Implications of Nonobstructive Coronary Artery Disease in Patients Undergoing Coronary Computed Tomographic Angiography for Acute Chest Pain
247
Prognostic Implications of Nonobstructive Coronary Plaques in Patients With Non–ST-Segment Elevation Myocardial Infarction: A Multidetector Computed Tomography Study
248
Prognostic Implications of Normal (<0.10 ng/ml) and Borderline (0.10 to 1.49 ng/ml) Troponin Elevation Levels in Critically Ill Patients Without Acute Coronary Syndrome
249
Prognostic Implications of Preoperative Atrial Fibrillation in Patients Undergoing Aortic Valve Replacement: Is There an Argument for Concomitant Arrhythmia Surgery?
250
Prognostic Implications of Prominent R Wave in Electrocardiographic Leads V1 or V2 in Patients With Acute Coronary Syndrome
251
Prognostic Implications of Restrictive Left Ventricular Filling in Acute Myocardial Infarction: Serial Doppler Echocardiographic Study
252
Prognostic implications of restrictive left ventricular filling in reperfused anterior acute myocardial infarction
253
Prognostic Implications of ST-Segment Elevation Resolution in Patients With ST-Segment Elevation Acute Myocardial Infarction Treated With Primary or Facilitated Percutaneous Coronary Intervention
254
Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction
255
Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic Cardiomyopathy
256
Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic Cardiomyopathy
257
Prognostic Implications of the High-Sensitive C-Reactive Protein in the Catheter Ablation of Atrial Fibrillation
258
Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis: Reexamining the “gold standard” for myocardial reperfusion assessment
259
Prognostic Importance of Atrial Fibrillation in Implantable Cardioverter-Defibrillator Patients
260
Prognostic importance of complete atrioventricular block complicating acute myocardial infarction
261
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes
262
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
263
Prognostic importance of elevated troponin T and creatine kinase after elective angioplasty
264
Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction
265
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies
266
Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease
267
Prognostic importance of isolated T-wave abnormalities
268
Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the bypass angioplasty revascularization investigation (BARI)
269
Prognostic importance of lymphopenia in West Nile encephalitis
270
Prognostic importance of marital quality for survival of congestive heart failure
271
Prognostic importance of new small Q waves following Non–ST-Elevation acute coronary syndromes
272
Prognostic importance of presenting symptoms in patients undergoing exercise testing for evaluation of known or suspected coronary disease
273
Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction
274
Prognostic importance of right ventricular infarction in an acute myocardial infarction cohort referred for contemporary percutaneous reperfusion therapy
275
Prognostic Importance of Scintigraphic Left Ventricular Cavity Dilation During Intravenous Dipyridamole Technetium-99m Sestamibi Myocardial Tomographic Imaging in Predicting Coronary Events
276
Prognostic Importance of Secondary Pulmonary Hypertension After Acute Myocardial Infarction
277
Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome
278
Prognostic importance of systolic and diastolic function after acute myocardial infarction
279
Prognostic importance of the length of ventricular tachycardia in patients with nonischemic congestive heart failure
280
Prognostic importance of the oxidized product of catecholamines, adrenolutin, in patients with severe heart failure
281
Prognostic importance of the quantification of myocardial viability in revascularized patients with coronary artery disease and moderate-to-severe left ventricular dysfunction
282
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia
283
Prognostic importance of troponin T and creatine kinase after elective angioplasty
284
Prognostic Importance of Wall Motion Abnormalities in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
285
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study
286
Prognostic indexes in breast cancer: comparison of the Nottingham and Adelaide indexes
287
Prognostic indicators and burns
288
Prognostic indicators for conventional complete denture therapy: A review of the literature
289
Prognostic indicators for conventional complete denture therapy: A review of the literature
290
Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles
291
Prognostic indicators of adverse renal outcome and death in acute kidney injury hospital survivors
292
Prognostic Indicators: Useful for Clinical Care?
293
Prognostic indices and screen-detected cancers: the size factor
294
Prognostic Influence of Diabetes Mellitus on Long-Term Clinical Outcomes and Stent Thrombosis After Drug-Eluting Stent Implantation in Asian Patients
295
Prognostic influence of multiple hepatic metastases from colorectal cancer
296
Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer
297
Prognostic influence of the third Gleason grade in prostatectomy specimens
298
Prognostic Information of Glycogen Phosphorylase Isoenzyme BB in Patients With Suspected Acute Coronary Syndrome
299
Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure
300
Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function
301
Prognostic Interplay of Coronary Artery Calcification and Underlying Vascular Dysfunction in Patients With Suspected Coronary Artery Disease
302
Prognostic markers for urothelial cancer: Obstacles and opportunities
303
Prognostic markers in chronic lympocytic leukaemia
304
Prognostic Markers in Thrombolytic Therapy: Looking Beyond Mortality
305
Prognostic methods in medicine
306
PROGNOSTIC MODELLING OF CRACK GROWTH IN A TENSIONED STEEL BAND
307
Prognostic models in chronic liver disease: validity, usefulness and future role
308
Prognostic models including the Child–Pugh, MELD and Mayo risk scores—where are we and where should we go?
309
Prognostic normative reasoning
310
Prognostic normative reasoning
311
Prognostic patch testing: The other kind of patch test
312
Prognostic patch testing: The other kind of patch test
313
Prognostic Performance of Multiple Biomarkers in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: Analysis From the MERLIN–TIMI 36 Trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non−ST-Elevation Acute Coronary Syndromes–Th
314
Prognostic personal credit risk model considering censored information
315
Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression
316
Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens
317
Prognostic predictors of gastrointestinal stromal tumors: a multi-institutional analysis of 102 patients with definition of a prognostic index
318
Prognostic relevance of AgNORs in tumor pathology
319
Prognostic relevance of cyclooxygenase-2 (COX-2) expression in Chinese patients with prostate cancer
320
Prognostic relevance of Masaoka and Müller-Hermelink classification in patients with thymic tumors
321
Prognostic Relevance of Metabolic Syndrome in Hypertensive Patients at Low-to-Medium Risk
322
Prognostic relevance of mitotic activity in patients with node negative breast cancer
323
Prognostic Relevance of Monosomy at the 13q14 Locus Detected by Fluorescence In Situ Hybridization in B-Cell Chronic Lymphocytic Leukemia
324
Prognostic relevance of occult tumour cells in lymph nodes in colorectal cancer
325
Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma
326
Prognostic relevance of receptor tyrosine kinase expression in breast cancer: A meta-analysis
327
Prognostic relevance of ultra-early doppler sonography in acute ischaemic stroke: a prospective multicentre study
328
Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy
329
Prognostic Role of Body Mass Index After Acute Myocardial Infarction
330
Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus Original Research Article
331
Prognostic role of cardiovascular risk factors for men with cardiomegaly (the Reykjavik study)
332
Prognostic Role of CMR Imaging After Myocardial Infarction
333
Prognostic role of cyclooxygenase-2 expression in esophageal carcinoma
334
Prognostic role of fish detected her-2/neu amplification in early onset breast cancer
335
Prognostic Role of Flow-Mediated Dilation and Cardiac Risk Factors in Post-Menopausal Women Original Research Article
336
Prognostic role of heart rate variability in patients with a recent acute myocardial infarction
337
Prognostic Role of Human Epidermal Growth Factor Receptor in Gastric Cancer: A Systematic Review and Meta-analysis
338
Prognostic role of immunosuppressive acidic protein in advanced ovarian cancer, , ,
339
Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer
340
Prognostic role of oestrogen, progesterone and androgen receptor in relation to patient age in patients with breast cancer
341
Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women
342
Prognostic Role of Spiritual Intelligence Components in Pregnant Women’s Depression, Anxiety, and Stress
343
Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease
344
Prognostic role of transesophageal echocardiography in acute type A aortic dissection
345
Prognostic Role of Troponin T Versus Troponin I in Unstable Angina Pectoris for Cardiac Events With Meta-Analysis Comparing Published Studies
346
Prognostic Serum Factors in Traumatic Brian Injury: A Systematic Review
347
Prognostic Significance and Determinants of Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance in Acute Reperfused Myocardial Infarction
348
Prognostic significance and different properties of survivin splicing variants in gastric cancer
349
Prognostic Significance of a Clearly Audible Fourth Heart Sound Detected a Month After an Acute Myocardial Infarction
350
Prognostic Significance of a Histologic Subtype in Small Adenocarcinoma of the Lung: The Impact of Nonbronchioloalveolar Carcinoma Components
351
Prognostic Significance of Admission Heart Failure in Patients With Non–ST-Elevation Acute Coronary Syndromes (from the Canadian Acute Coronary Syndrome Registries)
352
Prognostic significance of an elevated creatine kinase in the absence of an elevated troponin I during an acute coronary syndrome
353
Prognostic significance of anemia in patients with chronic systolic heart failure secondary to Chagas’ cardiomyopathy
354
Prognostic Significance of Angina Pectoris ≥30 Days Before Acute Myocardial Infarction in Patients ≥75 Years of Age
355
Prognostic significance of apoptosis in laryngeal cancer. A quantitative immunomorphological study
356
Prognostic Significance of Atrial Fibrillation and Severity of Symptoms of Heart Failure in Patients With Low Gradient Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
357
Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure
358
Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention
359
Prognostic significance of Aurora-A expression in human bladder cancer
360
Prognostic significance of axillary node and infraclavicular lymph node status after mastectomy
361
Prognostic significance of B7-H3 expression in patients with colorectal cancer: A meta-analysis
362
Prognostic significance of bcl-2 expression in resected pN2 non-small cell lung cancer
363
Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma
364
Prognostic significance of Bcl-xL gene expression in human colorectal cancer
365
Prognostic significance of blood pressure variability in essential hypertension.
366
Prognostic Significance of Bone-marrow Pattern and Immunophenotypic Score in B-chronic Lymphocytic Leukemia at Diagnosis
367
Prognostic Significance of Carcinoembryonic Antigen Level in Pleural Lavage Fluid for Patients With Lung Adenocarcinoma
368
Prognostic Significance of Carcinoembryonic Antigen Level in Pleural Lavage Fluid for Patients With Lung Adenocarcinoma
369
Prognostic significance of carcinoembryonic antigen levels in peritoneal washes in patients with gastric cancer
370
Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma
371
Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms
372
Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions
373
Prognostic significance of cerebrovascular disease in 11,526 chronic coronary artery disease patients
374
Prognostic significance of changes in the compliance of the pulmonary venous system after isosorbiddinitrate in patients with mitral stenosis
375
Prognostic significance of chronotropic response to dobutamine stress echocardiography in patients with peripheral arterial disease
376
Prognostic Significance of Circulating IL-10 and IL-6 Serum Levels in Colon Cancer Patients Undergoing Surgery
377
Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure
378
Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer
379
Prognostic significance of clinically silent coronary artery fistulas
380
Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era
381
Prognostic significance of coronary artery calcium in asymptomatic subjects with usual cardiovascular risk
382
Prognostic significance of coronary blood flow velocity patterns in patients with reperfused acute myocardial infarction and TIMI-2 flow
383
Prognostic significance of coronary blood flow velocity patterns in patients with reperfused acute myocardial infarction and TIMI-2 flow: Reply
384
Prognostic Significance of Coronary Calcific Deposits in Asymptomatic High-Risk Subjects
385
Prognostic Significance of Coronary Collaterals in Patients With Coronary Heart Disease Having Percutaneous Transluminal Coronary Angioplasty
386
Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction
387
Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study
388
Prognostic Significance of Cytokeratin Markers in Breast Cancer –a Meta Analysis
389
Prognostic significance of del(20q) in patients with hematological malignancies
390
Prognostic significance of diabetes as a predictor of survival after cardiac catheterization
391
Prognostic significance of diabetes in acute myocardial infarction. Are the differences linked to female gender?
392
Prognostic significance of diabetes in acute myocardial infarction. Are the differences linked to female gender?
393
Prognostic significance of difficulties in mobility in a five-year follow-up study of four birth cohorts
394
Prognostic significance of DNA ploidy in squamous cell lung carcinoma: is it really worth it?
395
Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group study
396
Prognostic significance of DNA ploidy pattern in osteosarcomas in association with chemotherapy
397
Prognostic significance of double product and inadequate double product response to maximal symptom-limited exercise stress testing after myocardial infarction in 6296 patients treated with thrombolytic agents
398
Prognostic significance of early short-term measurements of heart rate variability following acute myocardial infarction
399
Prognostic significance of echocardiographically defined mitral regurgitation early after acute myocardial infarction
400
Prognostic significance of echocardiographically estimated right ventricular shortening in advanced heart failure
401
Prognostic significance of EGF receptor expression in early glottic cancer
402
Prognostic Significance of Elevated Cardiac Troponin I After Heart Surgery
403
Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction
404
Prognostic significance of elevated troponin i after percutaneous coronary intervention
405
Prognostic Significance of Epicardial Blood Flow Before and After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes Original Research Article
406
Prognostic significance of ERRB3 overexpression in oral squamous cell carcinoma
407
Prognostic significance of erythropoietin expression in human renal cell carcinoma: Michael A, Politi E, Havranek E, Corbishley C, Karapanagiotou L, Anderson C, Relph K, Syrigos KN, Pandha H, Department of Oncology, St. George’s Hospital Medical School, L
408
Prognostic Significance of Exercise Induced Arrhythmias and Echocardiographic Variables in Hypertrophic Cardiomyopathy
409
Prognostic significance of exercise stress echocardiography in 3329 outpatients (5-year longitudinal study)
410
Prognostic significance of exercise-induced systemic hypertension in healthy subjects
411
Prognostic significance of fixed perfusion abnormalities on stress technetium-99m sestamibi single-photon emission computed tomography in patients without known coronary artery disease
412
Prognostic Significance of Fragmented QRS Complex for Predicting the Risk of Recurrent Cardiac Events in Patients With Q-Wave Myocardial Infarction
413
Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma
414
Prognostic significance of heart rate turbulence in patients undergoing coronary artery bypass grafting
415
Prognostic significance of heart rate variability in dilated cardiomyopathy
416
Prognostic significance of hepatic encephalopathy in patients with cirrhosis
417
Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung
418
Prognostic significance of history of stroke among 11507 patients with coronary artery disease
419
Prognostic Significance of Hyponatremia Among Ambulatory Patients With Heart Failure and Preserved and Reduced Ejection Fractions
420
Prognostic significance of immune activation after acute coronary syndromes
421
Prognostic Significance of Impaired Baroreflex Sensitivity Assessed from Phase IV of the Valsalva Maneuver in a Population-Based Sample of Middle-Aged Subjects
422
Prognostic significance of impairment of heart rate response to exercise: Impact of left ventricular function and myocardial ischemia
423
Prognostic Significance of Incident Complete Left Bundle Branch Block Observed Over a 40-Year Period
424
Prognostic Significance of Increased Left Ventricular Mass Index to Mortality and Sudden Death in Patients With Stable Coronary Heart Disease (from the Heart and Soul Study)
425
Prognostic significance of indeterminate lung nodules in renal cell carcinoma
426
Prognostic significance of intra-tumoral estradiol level in breast cancer patients
427
Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival
428
Prognostic significance of Ki-67 and topoisomerase II alpha expression in infiltrating ductal carcinoma of the breast
429
Prognostic significance of Ki-67 and topoisomerase II alpha expression in infiltrating ductal carcinoma of the breast
430
Prognostic significance of late-peaking left ventricular velocity contour in patients with aortic stenosis undergoing valve replacement, ,
431
Prognostic Significance of Left Anterior Hemiblock in Patients With Suspected Coronary Artery Disease Original Research Article
432
Prognostic Significance of Left Atrial Size in Patients With Hypertrophic Cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy)
433
Prognostic significance of left ventricular diastolic dysfunction in essential hypertension
434
Prognostic Significance of Left Ventricular Diastolic Dysfunction in Patients With Left Ventricular Hypertrophy and Systemic Hypertension (the LIFE Study)
435
Prognostic Significance of LGE by CMR in Aortic Stenosis Patients Undergoing Valve Replacement
436
Prognostic significance of low HDL-C and high triglycerides among diabetic coronary patients
437
Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma
438
Prognostic significance of lymph node reactivity in the control of pathologic negative node squamous cell carcinomas of the oral cavity
439
Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma
440
Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base
441
Prognostic Significance of Metastasis to the Highest Mediastinal Lymph Node in Nonsmall Cell Lung Cancer
442
Prognostic Significance of Metastatic Lymph Node Ratio in Patients with Gastric Cancer: an Evaluation in North-East of Iran
443
Prognostic Significance of MGMT Promoter Methylation in Egyptian GBM Patients: A Single-institution Experience
444
Prognostic Significance of MGMT Promoter Methylation in Patients with Glioblastoma Undergoing Surgical Intervention: A Retrospective Study in Northeastern Iran
445
Prognostic significance of microalbuminuria in non-diabetic patients with acute myocardial infarction
446
Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine
447
Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma
448
Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction
449
Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction
450
Prognostic Significance of MMP2 and MMP9 Functional Promoter Single Nucleotide Polymorphisms in Head and Neck Squamous Cell Carcinoma
451
Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy
452
Prognostic significance of morphometric endomyocardial biopsy analysis in patients with idiopathic dilated cardiomyopathy
453
Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
454
Prognostic Significance of Myocardial Fibrosis Quantification by Histopathology and Magnetic Resonance Imaging in Patients With Severe Aortic Valve Disease
455
Prognostic Significance of Myocardial Ischemia by Dobutamine Stress Echocardiography in Patients Without Angina Pectoris After Coronary Revascularization
456
Prognostic Significance of Myocardial Ischemia Detected by Ambulatory Electrocardiography, Exercise Treadmill Testing, and Electrocardiogram at Rest to Predict Cardiac Events by One Year (The Asymptomatic Cardiac Ischemia Pilot [ACIP] Study)
457
Prognostic Significance of Myocardial Ischemia During Dobutamine Stress Echocardiography in Asymptomatic Patients With Diabetes Mellitus and No Prior History of Coronary Events
458
Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung
459
Prognostic significance of newly acquired bundle branch block after aortic valve replacement
460
Prognostic significance of nocturnal BP for developing microalbuminuria in IDDM
461
Prognostic significance of nonfatal reinfarction during 3-year follow-up: Results of the thrombolysis in myocardial infarction (TIMI) phase II clinical trial
462
Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma
463
Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma
464
Prognostic Significance of Nonsustained Ventricular Tachycardia During Dobutamine Stress Echocardiography
465
Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain
466
Prognostic Significance of Nuclear βCatenin Expression in Patients with Colorectal Cancer from Iran
467
Prognostic Significance of Nuclear β-Catenin Expression in Patients with Colorectal Cancer from Iran
468
Prognostic Significance of Oxidative Stress Markers in Colitis Associated with Phenylbutazone Administration in Draft Horses
469
Prognostic significance of oxygen uptake kinetics during low level exercise in patients with heart failure
470
Prognostic significance of p16INK4a/p53 in Tunisian patients with breast carcinoma
471
Prognostic significance of p53 and p63 immunolocalisation in primary and matched lymph node metastasis in oral squamous cell carcinoma
472
Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin
473
Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies
474
Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma
475
Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma,
476
Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease
477
Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling
478
Prognostic Significance of Periprocedural Versus Spontaneously Occurring Myocardial Infarction After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes: An Analysis From the ACUITY (Acute Catheterization and Urgent Intervention T
479
Prognostic significance of persistent right ventricular dysfunction as assessed by radionuclide angiocardiography in patients with inferior wall acute myocardial infarction
480
Prognostic significance of positive surgical margins after radical prostatectomy among pT2 and pT3a prostate cancer
481
Prognostic significance of positive surgical margins after radical prostatectomy among pT2 and pT3a prostate cancer
482
Prognostic Significance of Postprocedural Sustained Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial)
483
Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: Results in 16,521 patients
484
Prognostic significance of precordial ST segment depression on admission electrocardiogram in patients with inferior wall myocardial infarction
485
Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy
486
Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy
487
Prognostic significance of prior preterm twin delivery on subsequent singleton pregnancy
488
Prognostic significance of prostate cancer originating from the transition zone
489
Prognostic Significance of QRS Duration in Patients With Suspected Coronary Artery Disease Referred for Noninvasive Evaluation of Myocardial Ischemia
490
Prognostic Significance of Quantitative QRS Duration
491
Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation
492
Prognostic significance of reactivation of telomerase in breast core biopsy specimens
493
Prognostic Significance of Reduction in Ki67 Index After Neoadjuvant Chemotherapy in Patients With Breast Cancer in Kerman Between 2009 an‎d 2014
494
Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE study)
495
Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarction
496
Prognostic significance of retrieved lymph nodes per specimenin resected rectal adenocarcinoma after preoperative chemoradiation therapy
497
Prognostic significance of RIN1 gene expression in human non-small cell lung cancer
498
Prognostic significance of selected immunological and biochemical parameters in the cerebrospinal fluid of Ossimi sheep with encephalitic listeriosis
499
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma
500
Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarc
501
Prognostic Significance of Serum Total Cholesterol and Triglyceride Levels in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)
502
Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent percutaneous coronary intervention for acute myocardial infarction
503
Prognostic significance of six-minute walk test in non-group 1 pulmonary hypertension
504
Prognostic Significance of Small Troponin I Rise After a Successful Elective Percutaneous Coronary Intervention of a Native Artery
505
Prognostic Significance of Small Troponin I Rise After a Successful Elective Percutaneous Coronary Intervention of a Native Artery
506
Prognostic significance of soluble interleukin-2 receptor-α in adenocarcinoma of the pancreas
507
Prognostic significance of spectral turbulence analysis of the signal-averaged electrocardiogram in patients with idiopathic dilated cardiomyopathy
508
Prognostic Significance of Spontaneous Echo Contrast in the Thoracic Aorta: Relation With Accelerated Clinical Progression of Coronary Artery Disease
509
Prognostic significance of ST segment depression in lateral leads I, aVL, V5 and V6 on the admission electrocardiogram in patients with a first acute myocardial infarction without ST segment elevation
510
Prognostic significance of ST segment monitoring early after myocardial infarction: GUSTO ECG substudy
511
Prognostic Significance of ST Segment Shift Early After Resolution of ST Elevation in Patients With Myocardial Infarction Treated With Thrombolytic Therapy: The GUSTO-I ST Segment Monitoring Substudy
512
Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells
513
Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma
514
Prognostic significance of ST-segment depression during adenosine perfusion imaging
515
Prognostic significance of ST-segment elevation during dobutamine stress echocardiography
516
Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung
517
Prognostic Significance of Systolic Blood Pressure Changes During Dobutamine-Atropine Stress Technetium-99m Sestamibi Perfusion Scintigraphy in Patients With Chest Pain and Known or Suspected Coronary Artery Disease
518
Prognostic Significance of Systolic Blood Pressure During Exercise Stress Testing
519
Prognostic Significance of Systolic Blood Pressure Increases in Men During Exercise Stress Testing
520
Prognostic significance of the admission electrocardiogram in acute myocardial infarction
521
Prognostic significance of the coexpression of p53 protein and c-erbB2 in breast cancer
522
Prognostic significance of the dobutamine echocardiography test in idiopathic dilated cardiomyopathy
523
Prognostic significance of the expression levels of the p16, p15, and p14 genes in dogs with high-grade lymphoma
524
Prognostic significance of the location of wall motion abnormalities during exercise echocardiography
525
Prognostic Significance of the Oxygen Uptake Efficiency Slope: Percent-Predicted Versus Actual Value
526
Prognostic significance of the pouch sign in fetuses with prenatally diagnosed esophageal atresia,
527
Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung
528
Prognostic Significance of the Tumor Suppressor Gene Maspin in Non–Small Cell Lung Cancer
529
Prognostic significance of thymomas in patients with myasthenia gravis
530
Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma
531
Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix
532
Prognostic significance of transient complete atrioventricular block during radiofrequency ablation of atrioventricular node reentrant tachycardia
533
Prognostic significance of transient ischemic episodes: Response to treatment shows improved prognosis Results of the total ischemic burden bisoprolol study (TIBBS) follow-up
534
Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction
535
Prognostic significance of trisomy 6 in an adult acute myeloid leukemia with t(8;21)
536
Prognostic Significance of Troponin Elevation and Right Ventricular Enlargement in Acute Pulmonary Embolism
537
Prognostic Significance of Troponin T Elevation in Patients Without Chest Pain
538
Prognostic significance of troponin T following elective percutaneous coronary intervention: The role of baseline troponin levels
539
Prognostic significance of tumor angiogenesis in epithelial ovarian cancer
540
Prognostic significance of tumor angiogenesis in primary fallopian tube cancer
541
Prognostic significance of tumor oxygenation in humans
542
Prognostic significance of two sub-categorization methods for the treatment of binge eating disorder: Negative affect and overvaluation predict, but do not moderate, specific outcomes
543
Prognostic Significance of Valvuloarterial Impedance and Left Ventricular Longitudinal Function in Asymptomatic Severe Aortic Stenosis Involving Three-Cuspid Valves
544
Prognostic Significance of VEGF-C Expression in Patients with Breast Cancer: A Meta-Analysis
545
Prognostic stratification of diabetic patients by exercise echocardiography
546
Prognostic Stratification of Patients with Left-Sided Endocarditis Determined at Admission
547
Prognostic stratification of patients with right bundle branch block using dobutamine stress echocardiography
548
Prognostic Stratification of Patients With Vasospastic Angina
549
Prognostic Stratification of Patients With Vasospastic Angina: A Comprehensive Clinical Risk Score Developed by the Japanese Coronary Spasm Association
550
Prognostic studies of canine and feline mammary tumours: The need for standardized procedures
551
Prognostic studies of mammary and other neoplasia in veterinary medicine: A new paradigm
552
Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke
553
Prognostic use of echocardiography 1 year after a myocardial infarction
554
Prognostic usefulness of an increase of N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure
555
Prognostic Usefulness of Anemia and N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Systolic Heart Failure
556
Prognostic Usefulness of Circulating High-Sensitivity Troponin T in Aortic Stenosis and Relation to Echocardiographic Indexes of Cardiac Function and Anatomy
557
Prognostic Usefulness of Clinical and Subclinical Peripheral Arterial Disease in Men With Stable Coronary Heart Disease
558
Prognostic Usefulness of C-Reactive Protein: Importance of the Diurnal Variation
559
Prognostic usefulness of dobutamine-induced ST-segment elevation and T-wave normalization after uncomplicated acute myocardial infarction
560
Prognostic Usefulness of Dyspnea Versus Fatigue as Reason for Exercise Test Termination in Patients With Heart Failure
561
Prognostic usefulness of echocardiographic dobutamine in younger (14 to 25 years) and older (40 to 55 years) patients with idiopathic dilated cardiomyopathy
562
Prognostic Usefulness of Free Fatty Acids in Patients With Stable Coronary Heart Disease
563
Prognostic Usefulness of Insulin-Like Growth Factor-Binding Protein 7 in Heart Failure With Reduced Ejection Fraction: A Novel Biomarker of Myocardial Diastolic Function?
564
Prognostic Usefulness of Left Ventricular Hypertrophy by Electrocardiography in Patients With Atrial Fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study)
565
Prognostic usefulness of left ventricular thrombus by echocardiography in dilated cardiomyopathy in predicting stroke, transient ischemic attack, and death
566
Prognostic usefulness of marginal troponin T elevation
567
Prognostic usefulness of plasma monocyte/macrophage and T-lymphocyte activation markers in patients with acute coronary syndromes
568
Prognostic usefulness of repeated echocardiographic evaluation after acute myocardial infarction
569
Prognostic Usefulness of Serial C-Reactive Protein Measurements in ST-Elevation Acute Myocardial Infarction
570
Prognostic Usefulness of Serum Uric Acid After Acute Myocardial Infarction (The Japanese Acute Coronary Syndrome Study)
571
Prognostic Usefulness of the Change in N-terminal pro B-type Natriuretic Peptide Levels to Predict Mortality in a Single Community Cohort Aged ≥70 Years
572
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy
573
Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy
574
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)
575
Prognostic Usefulness of White Blood Cell Count on Admission and One-Year Outcome in Patients With Non–ST-Segment Elevation Acute Chest Pain
576
Prognostic utility of a semiquantitative spinal deformity index
577
Prognostic Utility of BCIS Myocardial Jeopardy Score for Classification of Coronary Disease Burden and Completeness of Revascularization
578
Prognostic Utility of B-Type Natriuretic Peptide Assessment in Stable Low-Risk Outpatients With Nonischemic Cardiomyopathy After Decompensated Heart Failure Original Research Article
579
Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: The controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial Origin
580
Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure Original Research Article
581
Prognostic Utility of Left Ventricular End-Diastolic Pressure in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
582
Prognostic Utility of Metabolic Exercise Testing in Minimally Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
583
Prognostic Utility of Microvolt T-Wave Alternans in Risk Stratification of Patients With Ischemic Cardiomyopathy Original Research Article
584
Prognostic utility of myocardial blood flow assessed by N-13 ammonia positron emission tomography in patients with idiopathic dilated cardiomyopathy
585
Prognostic utility of myocardial viability assessment
586
Prognostic Utility of Neutrophil Gelatinase-Associated Lipocalin in Predicting Mortality and Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
587
Prognostic utility of single-photon emission computed tomography in adult patients with hypertrophic cardiomyopathy
588
Prognostic Utility of the SYNTAX Score in Patients With Single Versus Multivessel Disease Undergoing Percutaneous Coronary Intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] Trial)
589
Prognostic Validity of Red Cell Distribution Width in Neonatal Sepsis
590
Prognostic Value and Echocardiographic Determinants of Plasma Myeloperoxidase Levels in Chronic Heart Failure Original Research Article
591
Prognostic Value of New Electrocardiographic Method for Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension
592
Prognostic value of “high normal” serum creatinine in patients with essential hypertension
593
Prognostic value of 24-hour ambulatory blood pressure measurement for the onset of atrial fibrillation in treated patients with essential hypertension
594
Prognostic value of 2D echocardiography in patients presenting with acute chest pain and non-diagnostic ECG for ST-elevation myocardial infarction
595
Prognostic Value of 64-Slice Cardiac Computed Tomography: Severity of Coronary Artery Disease, Coronary Atherosclerosis, and Left Ventricular Ejection Fraction
596
Prognostic value of a doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy
597
Prognostic Value of a High On-Clopidogrel Treatment Platelet Reactivity in Bivalirudin Versus Abciximab Treated Non–ST-Segment Elevation Myocardial Infarction Patients: ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action fo
598
Prognostic Value of a Multimarker Approach for Patients Presenting to Hospital With Acute Chest Pain
599
Prognostic Value of a Multiparametric Risk Score in Patients Undergoing Dipyridamole Stress Echocardiography
600
Prognostic value of a negative stress echocardiographic study in diabetic patients
601
Prognostic Value of a Nine-Minute Treadmill Test in Patients Undergoing Myocardial Perfusion Scintigraphy
602
Prognostic Value of a Restrictive Mitral Filling Pattern in Patients With Systolic Heart Failure and an Implantable Cardioverter-Defibrillator
603
Prognostic value of absolute versus relative measures of the procedural result after successful coronary stenting: Importance of vessel size in predicting long-term freedom from target vessel revascularization
604
Prognostic Value of Adenosine Cardiac Magnetic Resonance Imaging in Patients Presenting With Chest Pain
605
Prognostic Value of Admission Fasting Glucose Levels in Patients With Acute Coronary Syndrome
606
Prognostic value of admission glucose in non-diabetic patients with myocardial infarction
607
Prognostic Value of Admission Hemoglobin Levels in ST-Segment Elevation Myocardial Infarction Patients Presenting With Cardiogenic Shock
608
Prognostic Value of Admission Myeloperoxidase Levels in Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock
609
Prognostic value of ambulatory blood pressure monitoring in refractory hypertension
610
Prognostic Value of Ambulatory Measurement of the Timing of Korotkoff Sounds in Elderly Hypertensives: A Pilot Study
611
Prognostic Value of an Abnormal Ankle–Brachial Index in Patients Receiving Drug-Eluting Stents
612
Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic dilated cardiomyopathy
613
Prognostic Value of an Exaggerated Exercise Blood Pressure Response in Patients With Diabetes Mellitus and Known or Suspected Coronary Artery Disease
614
Prognostic value of anemia in predicting sudden death of patients with diastolic heart failure
615
Prognostic Value of Angiographic Lesion Complexity in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial)
616
Prognostic Value of Aortic and Mitral Valve Calcium Detected by Contrast Cardiac Computed Tomography Angiography in Patients With Suspicion of Coronary Artery Disease
617
Prognostic Value of Aortic Valve Area Index in Asymptomatic Patients With Severe Aortic Stenosis
618
Prognostic Value of Automatically Detected Early Repolarization
619
Prognostic Value of BAALC Expression in Pediatric Acute Myeloid Leukemia: A Systematic Review
620
Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: The Antiarrhythmics Versus Implantable Defibrillators (AVID) trial
621
Prognostic Value of Brachial Artery Endothelial Function and Wall Thickness Original Research Article
622
Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma
623
Prognostic Value of B-type Natriuretic Peptide in Patients with Acute Coronary Syndromes
624
Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease: The PEACE Trial Original Research Article
625
Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: A pilot study
626
Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: A pilot study
627
Prognostic value of cardiac autonomic neuropathy independent and incremental to perfusion defects in patients with diabetes and suspected coronary artery disease
628
Prognostic Value of Cardiac Computed Tomography Angiography
629
Prognostic Value of Cardiac Computed Tomography Angiography: A Systematic Review and Meta-Analysis
630
Prognostic Value of Cardiac Troponin I Measured With a Highly Sensitive Assay in Patients With Stable Coronary Artery Disease
631
Prognostic Value of Cardiac Troponin T After Noncardiac Surgery: 6-Month Follow-Up Dat
632
Prognostic value of cardiac troponin T in unstable angina pectoris
633
Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions
634
Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy
635
Prognostic Value of Cardiopulmonary Exercise Variables in Chronic Heart Failure Patients With or Without Beta-Blocker Therapy
636
Prognostic value of cell-cycle regulators and cellular biomarkers in laryngeal squamous cell carcinoma
637
Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)
638
Prognostic Value of Chronic Kidney Disease After Transcatheter Aortic Valve Implantation
639
Prognostic value of clinical markers of reperfusion in patients with acute myocardial infarction treated by thrombolytic therapy,
640
Prognostic value of clinical signs and blood parameters in equids suffering from hepatic diseases
641
Prognostic Value of Combined Perfusion and Function by Stress Technetium-99m Sestamibi Gated SPECT Myocardial Perfusion Imaging in Patients With Suspected or Known Coronary Artery Disease
642
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions
643
Prognostic value of copeptin in patients with acute ischemic stroke
644
Prognostic value of coronary artery calcium screening in subjects with and without diabetes Original Research Article
645
Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease
646
Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography
647
Prognostic Value of Coronary Computed Tomographic Angiography in Asymptomatic Patients
648
Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations
649
Prognostic Value of Coronary Flow Reserve in Medically Treated Patients With Left Anterior Descending Coronary Disease With Stenosis 51% to 75% in Diameter
650
Prognostic Value of Coronary Flow Reserve on Long-Term Cardiovascular Outcomes in Patients With Chronic Kidney Disease
651
Prognostic Value of Coronary Magnetic Resonance Angiography for Prediction of Cardiac Events in Patients With Suspected Coronary Artery Disease
652
Prognostic value of corrected QT-interval prolongation in patients with unstable angina pectoris
653
Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction
654
Prognostic Value of C-Reactive Protein as an Inflammatory and N-Terminal Probrain Natriuretic Peptide as a Neurohumoral Marker in Acute Heart Failure (from the Korean Heart Failure Registry)
655
Prognostic value of C-reactive protein in patients with stress induced myocardial ischemia
656
Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction
657
Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study
658
Prognostic Value of Depression, Anxiety, and Anger in Hospitalized Cardiovascular Disease Patients for Predicting Adverse Cardiac Outcomes
659
Prognostic value of diastolic filling parameters derived using a novel image processing technique in patients ≥70 years of age with congestive heart failure
660
Prognostic Value of Diffusion MR Imaging and Clinical-Pathologic Factors in Patients with Rectal Cancer
661
Prognostic value of dipyridamole imaging in patients with left bundle branch block: review of 96 patients
662
Prognostic Value of Dipyridamole Stress Cardiovascular Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease Original Research Article
663
Prognostic value of DNA ploidy response to chemotherapy in human osteosarcomas
664
Prognostic Value of Dobutamine Echocardiography Early After Uncomplicated Acute Myocardial Infarction: Comparison With Exercise Electrocardiography
665
Prognostic value of dobutamine echocardiography in patients after q-wave or non–q-wave acute myocardial infarction
666
Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction
667
Prognostic value of dobutamine stress echocardiography in patients referred because of suspected coronary artery disease
668
Prognostic Value of Dobutamine Stress Echocardiography in Patients Undergoing Diagnostic Coronary Arteriography
669
Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease
670
Prognostic value of dobutamine stress echocardiography in patients with systemic hypertension and known or suspected coronary artery disease
671
Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease
672
Prognostic Value of Dobutamine Stress Echocardiography With Early Injection of Atropine With Versus Without Chronic Beta-Blocker Therapy in Patients With Known or Suspected Coronary Heart Disease
673
Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population
674
Prognostic value of dobutamine-atropine sestamibi imaging
675
Prognostic Value of Dobutamine–Atropine Stress Echocardiography Early After Acute Myocardial Infarction
676
Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain
677
Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure
678
Prognostic Value of Doppler Transmitral Flow Velocity Patterns in Acute Myocardial Infarction
679
Prognostic value of doppler ultrasound findings in patients with middle cerebral artery Ischemic stroke
680
Prognostic value of Doppler-derived myocardial performance index in patients with left ventricular systolic dysfunction
681
Prognostic Value of Early Acute Kidney Injury After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction
682
Prognostic Value of Early Exercise Testing After Coronary Stent Implantation
683
Prognostic Value of Early Exercise Testing After Coronary Stent Implantation: A Strategy of Routine Stress Testing After Percutaneous Coronary Intervention Is Not of Proven Benefit
684
Prognostic value of E-cadherin expression in thyroid follicular carcinoma
685
Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications
686
Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy
687
Prognostic value of electrocardiographic criteria for left ventricular hypertrophy
688
Prognostic Value of Electrocardiographic Measurements Before and After Cardiac Resynchronization Device Implantation in Patients With Heart Failure due to Ischemic or Nonischemic Cardiomyopathy
689
Prognostic value of electrophysiologic studies in brugada syndrome
690
Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure: Refining the Gut Hypothesis
691
Prognostic Value of Elevated SHIP2 Expression in Laryngeal Squamous Cell Carcinoma
692
Prognostic Value of Elevated White Blood Cell Count in Hypertension
693
Prognostic value of endocardial electromechanical mapping in patients with left ventricular dysfunction undergoing percutaneous coronary intervention
694
Prognostic value of endothelial function
695
Prognostic value of end-tidal carbon dioxide during exercise testing in heart failure
696
Prognostic Value Of End-Tidal Carbon Dioxide Pressures During Out-Of-Hospital Cardiac Arrest, ,
697
Prognostic value of energy metabolism in patients with viral liver cirrhosis
698
Prognostic Value of EVI1 Expression in Pediatric Acute Myeloid Leukemia: A Systematic Review
699
Prognostic value of exercise cardiac tomography performed late after percutaneous coronary intervention in symptomatic and symptom-free patients
700
Prognostic value of exercise echocardiography in 2,632 patients ≥65 years of age
701
Prognostic value of exercise echocardiography in patients after coronary artery bypass surgery
702
Prognostic value of exercise echocardiography in patients with classic angina pectoris
703
Prognostic Value of Exercise Echocardiography in Patients With Diabetes Mellitus and Known or Suspected Coronary Artery Disease
704
Prognostic value of exercise echocardiography in women in the community setting
705
Prognostic value of exercise echocardiographyin 5,798 patients: is there a gender difference?
706
Prognostic value of exercise stress myocardial perfusion imaging in patients with permanent pacemakers
707
Prognostic Value of Exercise Stress Technetium-99m-Tetrofosmin Myocardial Perfusion Imaging in Patients With Normal Baseline Electrocardiograms
708
Prognostic value of exercise testing in women after acute coronary syndromes (the Stockholm female coronary risk study)
709
Prognostic value of exercise thallium-201 imaging in a community population, , ,
710
Prognostic Value of Exercise Thallium-201 Imaging Performed Within 2 Years of Coronary Artery Bypass Graft Surgery
711
Prognostic Value of Exercise Tolerance Testing in Asymptomatic Chronic Nonischemic Mitral Regurgitation
712
Prognostic Value of FDG-PET, Based on the Revised Response Criteria, in Patients with Malignant Lymphoma: A Comparison with CT/MRI Evaluations, Based on the International Working Group/ Cotswolds Meeting Criteria
713
Prognostic value of fluorine-18-deoxyglucose (FDG) positron emission tomograpy (PET) in neuroendocrine tumors (NETs)
714
Prognostic Value of Fractional Flow Reserve: Linking Physiologic Severity to Clinical Outcomes
715
Prognostic value of fragmented QRS on a 12-lead ECG in patients with acute myocardial infarction
716
Prognostic Value of Free Plasma Homocysteine Levels in Patients Hospitalized With Acute Coronary Syndrome
717
Prognostic Value of Frontal QRS-T Angle in Patients Without Clinical Evidence of Cardiovascular Disease (from the Multi-Ethnic Study of Atherosclerosis)
718
Prognostic Value of Functional Performance for Mortality in Patients With Peripheral Artery Disease Original Research Article
719
Prognostic value of heart rate adjustment of exercise-induced ST segment depression in the multiple risk factor intervention trial
720
Prognostic value of heart rate recovery in patients with heart failure
721
Prognostic Value of Heart Rate Turbulence and Its Relation to Inflammation in Patients With Unstable Angina Pectoris
722
Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure
723
Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy
724
Prognostic Value of Heart Rate Variability in Chronic Congestive Heart Failure Secondary to Idiopathic or Ischemic Dilated Cardiomyopathy
725
Prognostic value of heart rate variability in idiopathic dilated cardiomyopathy
726
Prognostic value of hemodynamic findings from impedance cardiography in hypertensive stroke
727
Prognostic value of hemoglobin A1c in nondiabetic and diabetic patients with acute ischemic stroke
728
Prognostic Value of Hemoglobin A1C Levels in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention With Stent Implantation
729
Prognostic value of hepatocyte growth factor in haemophagocytic lymphohistiocytosis
730
Prognostic value of HER-2/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatment
731
Prognostic value of HER2/neu expression in patients with prostate cancer: a systematic review
732
Prognostic value of high dose dipyridamole echocardiography in patients with chronic coronary artery disease and preserved left ventricular function
733
Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons
734
Prognostic Value of High-Dose Dobutamine Stress Magnetic Resonance Imaging in 1,493 Consecutive Patients: Assessment of Myocardial Wall Motion and Perfusion
735
Prognostic Value of Histology in Resected Lung Cancer With Emphasis on the Relevance of the Adenocarcinoma Subtyping
736
Prognostic Value of HLA-G in Malignant Liver and Pancreas Lesions
737
Prognostic value of home heart rate for cardiovascular mortality in the general population: The Ohasama study
738
Prognostic value of human erythrocyte acetyl cholinesterase in acute organophosphate poisoning
739
Prognostic value of ictal onset patterns in postsurgical outcome of temporal lobe epilepsy
740
Prognostic value of immunofluorometrically quantifed P53 protein in ovarian carcinoma
741
Prognostic value of immunofluorometrically quantifed P53 protein in ovarian carcinoma
742
Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer
743
Prognostic Value of Impaired Fasting Glucose for Outcomes of Patients With Stable Angina Pectoris Treated With Percutaneous Coronary Interventions
744
Prognostic Value of Impaired Preoperative Ankle Reflex in Surgical Outcome of Lumbar Disc Herniation
745
Prognostic Value of Impaired Preoperative Ankle Reflex in Surgical Outcome of Lumbar Disc Herniation
746
Prognostic value of insulin-like growth factor-1 receptors in patients with colon/rectal cancer: Correlation with plasma prolactin
747
Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention
748
Prognostic value of interleukin-8 as a predictor of heart failure in patients with myocardial infarction and percutaneous intervention
749
Prognostic Value of Intraventricular Dyssynchrony According to Clinical Stage of Left Ventricular Impairment
750
Prognostic Value of Iodine-123-Metaiodobenzylguanidine Myocardial Uptake and Heart Rate Variability in Chronic Congestive Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy
751
Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women
752
Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes
753
Prognostic Value of KI6 Biomarker in Predict Short Time Prognosis of Low Grade Cervical Intraepithelial Neoplasia in HPV Negative and Positive Patients
754
Prognostic Value of Late Heart Rate Recovery After Treadmill Exercise
755
Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy
756
Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement
757
Prognostic value of left ventricular concentric remodeling in uncomplicated mild hypertension
758
Prognostic value of left ventricular dyssynchrony in patients with heart failure
759
Prognostic value of left ventricular dyssynchrony in patients with heart failure: Reply
760
Prognostic value of left ventricular hypertrophy and geometry in patients with a first, uncomplicated myocardial infarction
761
Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy
762
Prognostic value of left ventricular mass and its evolution during treatment in the bordeaux cohort of hypertensive patients
763
Prognostic Value of Left Ventricular Myocardial Performance Index in Patients Undergoing Coronary Artery Bypass Graft Surgery
764
Prognostic Value of Lesion Classification for the Clinical Outcome After Stent Placement
765
Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease
766
Prognostic Value of Location and Type of Myocardial Infarction in the Setting of Advanced Left Ventricular Dysfunction
767
Prognostic Value of Low Blood Glucose at the Presentation of E. coli Bacteremia
768
Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes
769
Prognostic Value of Lung Sestamibi Uptake in Myocardial Perfusion Imaging of Patients With Known or Suspected Coronary Artery Disease Original Research Article
770
Prognostic Value of Lymph Node Ratio in comparison to Lymph Node Metastases in Stage III Colon Cancer
771
Prognostic value of magnetic resonance spectroscopy in patients with diffuse axonal injury: a systematic literature review
772
Prognostic value of mechanical efficiency in ambulatory patients with idiopathic dilated cardiomyopathy in sinus rhythm
773
Prognostic value of mental stress testing in coronary artery disease
774
Prognostic Value of Midregional Pro-Adrenomedullin in Patients With Acute Myocardial Infarction: The LAMP (Leicester Acute Myocardial Infarction Peptide) Study Original Research Article
775
Prognostic Value of Mid-Regional Pro-Adrenomedullin Levels Taken on Admission and Discharge in Non–ST-Elevation Myocardial Infarction: The LAMP (Leicester Acute Myocardial Infarction Peptide) II Study
776
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
777
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
778
Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia
779
Prognostic value of mitotic counts in axillary node negative breast cancer patients with predominantly well-differentiated tumours
780
Prognostic Value of Monocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)
781
Prognostic Value of Multidetector Coronary Computed Tomographic Angiography for Prediction of All-Cause Mortality Original Research Article
782
Prognostic Value of Multidetector Coronary Computed Tomography Angiography
783
Prognostic Value of Multidetector Coronary Computed Tomography Angiography in Relation to Exercise Electrocardiogram in Patients With Suspected Coronary Artery Disease
784
Prognostic Value of Multiple Biomarkers in American Indians Free of Clinically Overt Cardiovascular Disease (from the Strong Heart Study)
785
Prognostic Value of Multislice Computed Tomography and Gated Single-Photon Emission Computed Tomography in Patients With Suspected Coronary Artery Disease
786
Prognostic Value of Multislice Computed Tomography Coronary Angiography in Patients With Known or Suspected Coronary Artery Disease Original Research Article
787
Prognostic value of mutations and a germ line polymorphism of the p53 gene in non-small cell lung carcinoma: association with clinicopathological features
788
Prognostic value of myeloperoxidase in patients with chest pain
789
Prognostic Value of Myocardial Contrast Delayed Enhancement With 64-Slice Multidetector Computed Tomography After Acute Myocardial Infarction
790
Prognostic Value of Myocardial Contrast Echocardiography in Patients Presenting to Hospital With Acute Chest Pain and Negative Troponin
791
Prognostic Value of Myocardial Infarct Size and Contractile Reserve Using Magnetic Resonance Imaging
792
Prognostic Value of Myocardial Injury Following Transcatheter Aortic Valve Implantation
793
Prognostic Value of Myocardial Ischemic Electrocardiographic Response in Patients With Normal Stress Echocardiographic Study
794
Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation
795
Prognostic Value of Myocardial Scar in Atrial Fibrillation
796
Prognostic value of myocardial viability and ischemi detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis
797
Prognostic Value of Myocardial Viability by Delayed-Enhanced Magnetic Resonance in Patients With Coronary Artery Disease and Low Ejection Fraction: Impact of Revascularization Therapy
798
Prognostic Value of Myocardial Viability Detected by Myocardial Contrast Echocardiography Early After Acute Myocardial Infarction Original Research Article
799
Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction
800
Prognostic value of negative dobutamine stress echo in women with intermediate probability of coronary artery disease
801
Prognostic value of negative transesophageal dobutamine stress echocardiography in men at high risk for coronary artery disease
802
Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease
803
Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure
804
Prognostic Value of Neutrophil to Lymphocyte Ratio in Patients Presenting With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
805
Prognostic Value of Neutrophil to Lymphocyte Ratio on Pathologic Findings of Transrectal Ultrasonography Guided Biopsy of Prostate
806
Prognostic Value of Nocturnal Melatonin Levels as a Novel Marker in Patients With ST-Segment Elevation Myocardial Infarction
807
Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction
808
Prognostic value of noninvasive testing one year after orthotopic cardiac transplantation
809
Prognostic Value of Noninvasively Obtained Left Ventricular Contractile Reserve in Patients With Severe Heart Failure
810
Prognostic Value of Normal Adenosine-Stress Cardiac Magnetic Resonance Imaging
811
Prognostic Value of Normal Exercise Echocardiography in a One-Year Follow-up
812
Prognostic value of normal stress echocardiogram in patients with suspected coronary artery disease—A British general hospital experience
813
Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes
814
Prognostic value of N-terminal proatrial natriuretic factor plasm levels measured within the first 12 hours after myocardial infarction
815
Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Hypertrophic Cardiomyopathy
816
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Active Infective Endocarditis
817
Prognostic value of N-terminal pro-B-type natriuretic peptide, cytokines and sCD40L in patients with acute heart failure  
818
Prognostic Value of N-Terminal Pro–Type-B Natriuretic Peptide and Doppler Left Ventricular Diastolic Variables in Patients With Chronic Systolic Heart Failure Stabilized by Therapy
819
Prognostic value of nucleolar organizer regions in supraglottic carcinoma
820
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction Original Research Article
821
Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatin
822
Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement: Frank I, Cheville JC, Blute ML, Lohse CM, Karnes RJ, Weaver AL, Sebo TJ, Nehra A, Zincke H, Department of Urology, Mayo Clinic, R
823
Prognostic value of p53 in renal cell carcinoma
824
Prognostic Value of P63, Maspin, and MMP-2 Expression in Salivary Gland Adenoid Cystic Carcinoma
825
Prognostic Value of Pacing-Induced Mechanical Alternans in Patients With Mild-to-Moderate Idiopathic Dilated Cardiomyopathy in Sinus Rhythm Original Research Article
826
Prognostic value of peak exercise systolic blood pressure on long-term survival after myocardial infarction
827
Prognostic value of pentraxin 3 in patients with chronic heart failure
828
Prognostic value of pharmacologic stress echocardiography in patients with left bundle branch block
829
Prognostic Value of Pharmacological Stress Echocardiography in Diabetic and Nondiabetic Patients With Known or Suspected Coronary Artery Disease Original Research Article
830
Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease
831
Prognostic Value of Plasma Brain Natriuretic Peptide, Urea Nitrogen, and Creatinine in Outpatients >70 Years of Age With Heart Failure
832
Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction
833
Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure Original Research Article
834
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)
835
Prognostic Value of Plasma Fibrinolysis Activation Markers in Cardiovascular Disease
836
Prognostic Value of Plasma Ghrelin in Predicting the Outcome of Patients with Chronic Heart Failure
837
Prognostic value of plasma interleukin-6 concentrations and the −174 G > C and −572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis
838
Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris
839
Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy
840
Prognostic Value of Plasma Renin Activity in Heart Failure
841
Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure
842
Prognostic value of portal haemodynamics
843
Prognostic value of positive pleural lavage in patients with lung cancer resection
844
Prognostic value of predischarge dipyridamole technetium 99m sestamibi myocardial tomography in medically treated patients with unstable angina
845
Prognostic value of predischarge dobutamine stress echocardiography in chest pain patients with a negative cardiac troponin T
846
Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: Insights from GUSTO I Economics and Quality of Life substudy
847
Prognostic value of predischarge exercise stress echocardiography after acute myocardial infarction
848
Prognostic value of predischarge exercise testing, ejection fraction, and ventricular ectopic activity in acute myocardial infarction treated with streptokinase
849
Prognostic Value of Preoperative Atrial Fibrillation in Patients With Aortic Stenosis and Low Ejection Fraction Having Aortic Valve Replacement
850
PROGNOSTIC VALUE OF PREOPERATIVE SCIATALGIA IN LUMBAR DISC SURGERY
851
Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC
852
Prognostic value of proliferating cell nuclear antigen in Wilms» tumour in children
853
Prognostic value of prominent DCIS component in the breast-conserving therapy of stage I and II invasive ductal breast cancer
854
Prognostic value of prostate specific antigen before, during and after radiotherapy
855
Prognostic value of pseudonormal and restrictive filling patterns on left ventricular remodelingand cardiac events after coronary artery bypass grafting
856
Prognostic value of pulmonary venous flow Doppler signal in left ventricular dysfunction: contribution of the difference in duration of pulmonary venous and mitral flow at atrial contraction
857
Prognostic Value of Pulse-Wave Tissue Doppler Parameters in Patients With Systolic Heart Failure
858
Prognostic Value of QRS Duration After Transcatheter Aortic Valve Implantation for Aortic Stenosis Using the CoreValve
859
Prognostic value of QT dispersion in acute stroke
860
Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic dysfunction: Results from a cohort of 2265 patients with an ejection fraction of ≤40%
861
Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention
862
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
863
Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET*1
864
Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type ii diabetes mellitus Original Research Article
865
Prognostic Value of Renal Dysfunction for the Prediction of Outcome Versus Results of Computed Tomographic Coronary Angiography
866
Prognostic value of renal function in patients with cardiac resynchronization therapy
867
Prognostic value of resting end-tidal carbon dioxide in patients with heart failure
868
Prognostic value of resting thallium-201 imaging: Measurement of infarction but not ischemi predicts outcome
869
Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy
870
Prognostic Value of Right Heart Catheterization Hemodynamic Dat in Surgically Treated Patients with Coronary Artery Disease
871
Prognostic value of right ventricular myocardial performance index in patients undergoing coronary artery bypass surgery
872
Prognostic Value of Routine Preoperative Electrocardiography in Patients Undergoing Noncardiac Surgery
873
Prognostic Value of Self-Reported Versus Objectively Measured Functional Capacity in Patients With Heart Failure: Results From the TIME-CHF (Trial of Intensified Versus Standard Medical Therapy in Elderly Patients With Congestive Heart Failure)
874
Prognostic value of serial changes in left ventricular mass in essential hypertension
875
Prognostic Value of Serial Electrocardiographic Voltage and Repolarization Changes in Essential Hypertension: The HEART Survey Study
876
Prognostic Value of Serial Global Longitudinal Strain Measured by Two-Dimensional Speckle Tracking Echocardiography in Patients With ST-Segment Elevation Myocardial Infarction
877
Prognostic Value of Serum B-Type Natriuretic Peptide in Early Mortality and Morbidity of Children with Congenital Heart Disease after Open Heart Surgery
878
Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: A two-year outcome analysis
879
Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis
880
Prognostic value of serum interleukin-6 (IL-6) levels in long term care
881
Prognostic value of simultaneous perfusion and function assessment using technetium-99m sestamibi
882
Prognostic Value of Site SYNTAX Score and Rationale for Combining Anatomic and Clinical Factors in Decision Making: Insights From the SYNTAX Trial
883
Prognostic Value of Slow Resolution of ST-Segment Elevation Following Successful Direct Percutaneous Transluminal Coronary Angioplasty for Recovery of Left Ventricular Function
884
Prognostic Value of Soluble ST2 (sST2) Serum Level in Congenital Heart Disease Children with Heart Failure
885
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb
886
Prognostic value of strain and strain rate in the prediction of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting: a systematic literature review
887
Prognostic Value of Stress Cardiac Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease: A Systematic Review and Meta-Analysis
888
Prognostic value of stress dobutamine technetium-99m sestamibi single-photon emission computed tomography (SPECT) in patients with suspected coronary artery disease
889
Prognostic Value of Stress Echocardiogram in Patients With Angiographically Significant Coronary Artery Disease
890
Prognostic Value of Stress Echocardiography in the Evaluation of Atypical Chest Pain Patients Without Known Coronary Artery Disease
891
Prognostic value of stress-gated Tc-99m sestamibi SPECT after acute myocardial infarction
892
Prognostic Value of ST-T Abnormalities and Left High R Waves With Cardiovascular Mortality in Japanese (24-Year Follow-Up of NIPPON DATA80)
893
Prognostic value of systemic blood pressure response during exercise in community-based patient population with hypertrophic cardiomyopathy
894
Prognostic value of Th1/Th2 ratio in rheumatoid arthritis
895
Prognostic value of Th1/Th2 ratio in rheumatoid arthritis
896
Prognostic value of Th1/Th2 ratio in rheumatoid arthritis
897
Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (the Emory Angioplasty versus Surgery Trial [EAST])
898
Prognostic value of the admission electrocardiogram in patients with unstable angina/non–ST-segment elevation myocardial infarction treated with very early revascularization
899
Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction
900
Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer
901
Prognostic Value of the Duke Treadmill Score in Asymptomatic Women
902
Prognostic value of the Duke Treadmill Score in diabetic patients
903
Prognostic value of the Duke treadmill score in the elderly
904
Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation A prospective multicenter Italian study
905
Prognostic value of the high-mobility group box-1 in young patients with chest pain
906
Prognostic value of the metabolic syndrome in essential hypertension Original Research Article
907
Prognostic Value of the Modified American College of Cardiology/American Heart Association Lesion Morphology Classification for Clinical Outcome After Sirolimus-Eluting Stent Placement (Results of the Prospective Multicenter German Cypher Registry)
908
Prognostic Value of the Shock Index Along With Transthoracic Echocardiography in Risk Stratification of Patients With Acute Pulmonary Embolism
909
Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic ana nonischemic cardiomyopathy
910
Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa
911
Prognostic Value of the SYNTAX Score in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) Trial
912
Prognostic value of the VE/VCO2 slope calculated from different time intervals in patients with suspected heart failure
913
Prognostic Value of Thrombolysis, Coronary Artery Patency, Signal-Averaged Electrocardiography, Left Ventricular Ejection Fraction, and Holter Electrocardiographic Monitoring for Life-Threatening Ventricular Arrhythmias After a First Acute Myocardial Infa
914
Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure
915
Prognostic value of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with gastric cancer
916
Prognostic Value of Total Bilirubin in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Coronary Intervention
917
Prognostic Value of Total Lymph Node Identified and Ratio of Lymph Nodes in Resected Colorectal Cancer
918
Prognostic Value of Total Lymph Node Identified and Ratio of Lymph Nodes in Resected Colorectal Cancer
919
Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon
920
Prognostic value of training-induced change in peak exercise capacity in patients with myocardial infarcts and patients with coronary bypass surgery
921
Prognostic Value of Transient and Sustained Increase in In-Hospital Creatinine on Outcomes of Patients Admitted With Acute Coronary Syndrome
922
Prognostic value of treatment-induced changes in twenty-four-hour mean and pulse pressures in adult hypertensive patients
923
Prognostic Value of Troponin T after Elective Percutaneous Coronary Intervention
924
Prognostic value of tumoral ploidy in a series of Spanish patients with acute lymphoblastic leukemia
925
Prognostic Value of T-Wave Alternans in Patients With Heart Failure Due to Nonischemic Cardiomyopathy: Results of the ALPHA Study Original Research Article
926
Prognostic Value of Uric Acid in Patients With Acute Coronary Syndromes
927
Prognostic Value of Uric Acid in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Coronary Intervention
928
Prognostic value of uterine artery doppler velocimetry in growth-restricted fetuses delivered near term
929
Prognostic value of vascular endothelial growth factor and tumor necrosis factor alfa in myelodysplastic syndrome
930
Prognostic Values of Estrogen and Progesterone Expression Receptors in Ovarian Papillary Serous Carcinoma
931
Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer
932
Prognostic Values of Proliferative Markers ki-67 and repp86 in Breast Cancer
933
Prognostic Values of Various Markers in Evaluation of Patients With Chest Pain
934
Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer
935
Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations
936
Prognosticating scale-forming properties of water
937
Prognostication and risk stratification by assessment of left atrioventricular plane displacement in patients with myocardial infarction
938
Prognostication in cancer of unknown primary (CUP): Development of a prognostic algorithm in 311 cases and review of the literature
939
Prognostication in Cardiac Patients
940
Prognostication of Breast Cancer in Ghanaian Women Receiving Modified Radical Mastectomy: A Retrospective Histopathological Study at Korle-Bu Teaching Hospital, Accra, Ghana
941
Prognostication of energy consumption and greenhouse gas (GHG) emissions analysis of apple production in West Azarbayjan of Iran using Artificial Neural Network
942
Prognostication of environmental indices in potato production using artificial neural networks
943
Prognostics
944
Prognostics 101: A tutorial for particle filter-based prognostics algorithm using Matlab
945
Prognostics 101: A tutorial for particle filter-based prognostics algorithm using Matlab
946
Prognostics and Health Management of PEMFC – State of the art and remaining challenges
947
Prognostics of lumen maintenance for High power white light emitting diodes using a nonlinear filter-based approach
948
Prognostics of lumen maintenance for High power white light emitting diodes using a nonlinear filter-based approach
949
Prognostics of PEM fuel cell in a particle filtering framework
950
Prognostics-based risk mitigation for telecom equipment under free air cooling conditions
951
Prognotic Factor Analyi in Par Plana Vitrectomy for Retinal Detachment Attributable to Macular Hole in High Myopia: A Multicenter tudy Original Reearch Article
952
Prognotic factor in uveal melanoma
953
Prognotic factor influencing viual outcome of photodynamic therapy for ubfoveal choroidal neovacularization in pathologic myopia
954
Prognotic value of cell-cycle marker in ocular adnexal lymphoma: an aement of 230 cae
955
PROGRA2 experiment: New results for dust clouds and regoliths analogs Original Research Article
956
Progradation of the paleo-Danube shelf margin across the Pannonian Basin during the Late Miocene and Early Pliocene
957
Prograde and retrograde history of the Junction School eclogite, California, and an evaluation of garnet–phengite–clinopyroxene thermobarometry
958
Prograde destruction and formation of monazite and allanite during contact and regional metamorphism of pelites: petrology and geochronology
959
Prograde garnet growth along complex P–T–t paths: results from numerical experiments on polyphase garnet from the Wölz Complex (Austroalpine basement)
960
Prograde garnet-bearing ultramafic rocks from the Tromsø Nappe, northern Scandinavian Caledonides
961
Prograde lawsonite during the flow of continental crust in the Alpine subduction: Strain vs. metamorphism partitioning, a field-analysis approach to infer tectonometamorphic evolutions (Sesia-Lanzo Zone, Western Italian Alps)
962
Prograde metamorphic evolution and development of chloritoid-bearing eclogitic assemblages in subcontinental metagabbro (Sesia–Lanzo zone, Italy)
963
Prograde metamorphism, decompressional partial melting and subsequent melt fractional crystallization in the Weihai migmatitic gneisses, Sulu UHP terrane, eastern China
964
Prograde metamorphism, strain evolution, and collapse of footwalls of thick thrust sheets: a case study from the Mesozoic Sevier hinterland U.S.A.
965
Prograde mica 40Ar/39Ar growth ages recorded in high pressure rocks (Syros, Cyclades, Greece)
966
Prograded Holocene beach ridges with superimposed dunes in north-east Ireland: mechanisms and timescales of fine and coarse beach sediment decoupling and deposition
967
Prograf Concentrations in Liver Transplantation: Correlation With Headache and Other Neurotoxic Complications?
968
Program
969
Program
970
Program analysis via graph reachability
971
Program Analysis with Partial Transfer Functions
972
Program Analysis with Partial Transfer Functions
973
Program and Verify Word-Line Voltage Regulator for Multilevel Flash Memories
974
Program announcement
975
Program Burn Algorithms Based on Detonation Shock Dynamics: Discrete Approximations of Detonation Flows with Discontinuous Front Models
976
Program death-1 regulates peripheral T cell tolerance via an anergy-independent mechanism
977
Program Development Schemata as Derived Rules
978
Program directors in surgery agree that residents should be formally trained in business and practice management
979
Program ENERGY: Scientists and students in the classroom tackling type 2 diabetes and obesity in elementary schools.
980
Program entanglement, feature interaction and the feature language extensions
981
Program equilibrium
982
Program evaluation and incentives for administrators of energy-efficiency programs: Can evaluation solve the principal/agent problem?
983
Program evaluation as a decision problem
984
Program Evaluation of a Community Crisis Stabilization Program
985
Program evaluation of an integrated basic science medical curriculum in Shiraz Medical School, using CIPP evaluation model
986
Program Evaluation: Forms and Approaches: J.M. Owen, P.J. Rogers; International Edition, Sage, London, 1999, 312 pages, hardcover, ISBN 0-761-96177-1 (US$ 78)
987
Program families: Program construction by context independent refinements
988
Program for calculating SU(4) Clebsch–Gordan coefficients Original Research Article
989
Program for Chinese children with developmental disabilities—the Hong Kong model
990
Program for computer simulation on photoproduction of mesons decaying into two photons
991
Program for Cooperative Cataloging: BIBCO Records: Analysis of Quality
992
Program for Cooperative Cataloging: The Indiana Experience
993
Program for generating tables of SU(3) ⊃ SU(2) ⊗ U(1) coupling coefficients Original Research Article
994
Program for the control of subclinical mastitis in dairy Chios breed ewes during lactation
995
Program integrity in primary and early secondary prevention: are implementation effects out of control?
996
Program Konferencji
997
Program management and the creative art of coopetition: Dealing with potential tensions and synergies between spatial development projects
998
Program management organization maturity integrated model for mega construction programs in China
999
Program of MPND-2003
1000
Program of the 7th International Food Data Conference, Food Composition and Biodiversity, Sao Paulo, Brazil, 21-24 October 2007
بازگشت